Oracle (NYSE:ORCL - Get Free Report) had its target price raised by stock analysts at UBS Group from $200.00 to $225.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the enterprise software provider's stock. UBS Group's price target points to a potential upside of 12.69% from the stock's previous close.
Other analysts have also issued research reports about the stock. CIBC reiterated a "buy" rating on shares of Oracle in a research note on Monday. KeyCorp increased their price target on Oracle from $200.00 to $225.00 and gave the stock an "overweight" rating in a research note on Thursday. Wall Street Zen downgraded Oracle from a "buy" rating to a "hold" rating in a research note on Wednesday, February 19th. Morgan Stanley reaffirmed a "positive" rating on shares of Oracle in a report on Monday. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Oracle from $200.00 to $240.00 and gave the company a "buy" rating in a report on Thursday. Twelve equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $192.30.
Get Our Latest Stock Report on Oracle
Oracle Stock Up 13.2%
ORCL stock traded up $23.29 during mid-day trading on Thursday, hitting $199.67. 54,558,768 shares of the company were exchanged, compared to its average volume of 9,567,888. The firm has a fifty day simple moving average of $149.60 and a 200 day simple moving average of $160.36. The company has a market capitalization of $558.47 billion, a PE ratio of 48.82, a price-to-earnings-growth ratio of 3.46 and a beta of 1.32. Oracle has a twelve month low of $118.86 and a twelve month high of $202.43. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65.
Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.06. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The business had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. During the same period last year, the firm earned $1.63 earnings per share. The company's revenue for the quarter was up 11.3% compared to the same quarter last year. On average, research analysts forecast that Oracle will post 5 earnings per share for the current fiscal year.
Insider Transactions at Oracle
In other Oracle news, Director Naomi O. Seligman sold 2,000 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the completion of the transaction, the director now owns 34,630 shares of the company's stock, valued at $5,049,400.30. This represents a 5.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Leon E. Panetta sold 17,500 shares of Oracle stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $151.24, for a total transaction of $2,646,700.00. Following the sale, the director now owns 58,090 shares in the company, valued at $8,785,531.60. This represents a 23.15% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,366 shares of company stock worth $4,015,723. Insiders own 42.20% of the company's stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Norges Bank bought a new position in Oracle during the 4th quarter valued at about $2,216,314,000. Raymond James Financial Inc. acquired a new stake in shares of Oracle during the fourth quarter worth approximately $930,095,000. Nuveen LLC bought a new position in shares of Oracle in the first quarter valued at approximately $732,692,000. GAMMA Investing LLC boosted its holdings in shares of Oracle by 15,012.3% in the 1st quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock worth $664,810,000 after acquiring an additional 4,723,631 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of Oracle by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock worth $22,498,982,000 after acquiring an additional 3,513,464 shares in the last quarter. 42.44% of the stock is owned by institutional investors.
About Oracle
(
Get Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.